Ace Therapeutics is committed to supplying high-quality antibodies associated with stroke growth & development to our clients at cost-effective prices. These antibodies have been extensively tested and validated to ensure their specificity and reliability. Our diverse portfolio of antibodies and assay kits target key molecules involved in stroke growth and development.
Neuronal growth and development begin during the embryonic stage and are influenced by a variety of hormones. When a stroke occurs, peripheral neurons tend to remodel through mechanisms of neuroplasticity and form new neuronal connections to compensate for the loss of function in the damaged area. This process is called neural remodeling.
Ace Therapeutics offers a comprehensive catalog of research reagents and products for studying stroke-related neuronal growth and development, including, but not limited to, CXCR4 antibodies, GAP43 antibodies, p75 NGF receptor antibodies, and NT-4 antibodies.
Please access our all-series neuronal growth & development antibodies or contact our scientist for personalized assistance.
We are committed to accelerating progress in stroke research and drug development.